Because deregulation of these pathways in terms of genetic mutations and amplification has been related to several human cancers, including Merkel cell carcinoma (MCC), a skin cancer caused by MCPyV infection, mTOR and its related pathways are studied as a key target for the potential treatment of MCC (20, –, 23). This evidence concerns the gene MTOR and Merkel cell skin cancer.